Translating Biological Targets into Valuable Drug Molecules Company Profile Drug Discovery Services iNovacia-Provid Alliance News Careers Contact 6/10/2008 The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia 12/5/2007 Expert drug discovery service companies, iNovacia and Provid, establish strategic alliance 9/10/2007 Provid CEO leads panel at Pharma ChemOutsourcing conference 12/19/2006 Edison Innovation Fund Makes Investment in North Brunswick-Based Provid Pharmaceuticals 10/17/2005 Provid Pharmaceuticals to Support Drug Discovery for Palatin Technologies 9/29/2005 Provid Announces New National Cancer Institute Contract 5/10/2005 Provid Pharmaceuticals announces move to expanded laboratories in North Brunswick,NJ 5/10/2005 Provid Pharmaceuticals Announces Celiac Disease Program and Grant 4/20/2005 Commission names first New Jersey Technology Fellows 3/1/2005 Provid Pharmaceuticals receives SBIR grant to study role of Provid compounds in cardiac function 9/20/2004 Provid Pharmaceuticals receives NIH grant to fund multiple sclerosis research 6/1/2004 Provid Pharmaceuticals selected for hit-to-lead and lead optimization medicinal chemistry support for National Cancer Institute.   Home  |   Contact Us

Disclaimer Copyright 2008